Innoscripta SE is a software company specializing in cloud-based compliance software for research and development. It provides R&D tax incentives consulting.
2012
n/a
Last FY Revenue $76.2M
Last FY EBITDA $44.4M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Innoscripta achieved revenue of $76.2M and an EBITDA of $44.4M.
Innoscripta expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Innoscripta valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $76.2M | XXX | XXX | XXX |
Gross Profit | XXX | $74.5M | XXX | XXX | XXX |
Gross Margin | XXX | 98% | XXX | XXX | XXX |
EBITDA | XXX | $44.4M | XXX | XXX | XXX |
EBITDA Margin | XXX | 58% | XXX | XXX | XXX |
EBIT | XXX | $44.0M | XXX | XXX | XXX |
EBIT Margin | XXX | 58% | XXX | XXX | XXX |
Net Profit | XXX | $29.6M | XXX | XXX | XXX |
Net Margin | XXX | 39% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 14, 2025, Innoscripta's stock price is EUR 104 (or $123).
Innoscripta has current market cap of EUR 1.0B (or $1.2B), and EV of EUR 1.0B (or $1.2B).
See Innoscripta trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.2B | $1.2B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 14, 2025, Innoscripta has market cap of $1.2B and EV of $1.2B.
Innoscripta's trades at 15.6x EV/Revenue multiple, and 26.9x EV/EBITDA.
Equity research analysts estimate Innoscripta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Innoscripta's P/E ratio is not available.
See valuation multiples for Innoscripta and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
EV (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 15.6x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | 26.9x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | 27.1x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | 41.6x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | 50.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialInnoscripta's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Innoscripta's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Innoscripta's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Innoscripta and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | 48% | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | 58% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | 88% | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Cape Range | XXX | XXX | XXX | XXX | XXX | XXX |
Credit Clear | XXX | XXX | XXX | XXX | XXX | XXX |
IODM | XXX | XXX | XXX | XXX | XXX | XXX |
Reckon | XXX | XXX | XXX | XXX | XXX | XXX |
Xero | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Innoscripta acquired XXX companies to date.
Last acquisition by Innoscripta was XXXXXXXX, XXXXX XXXXX XXXXXX . Innoscripta acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Innoscripta founded? | Innoscripta was founded in 2012. |
Where is Innoscripta headquartered? | Innoscripta is headquartered in Germany. |
Is Innoscripta publicy listed? | Yes, Innoscripta is a public company listed on FRA. |
What is the stock symbol of Innoscripta? | Innoscripta trades under 1INN ticker. |
When did Innoscripta go public? | Innoscripta went public in 2025. |
Who are competitors of Innoscripta? | Similar companies to Innoscripta include e.g. Cape Range, Credit Clear, IODM, Reckon. |
What is the current market cap of Innoscripta? | Innoscripta's current market cap is $1.2B |
Is Innoscripta profitable? | Yes, Innoscripta is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.